STATE STREET CORP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$6,361,997
+46.7%
454,104
+8.4%
0.00%
Q2 2023$4,337,116
+290.4%
419,045
+248.6%
0.00%
Q1 2023$1,110,851
-44.4%
120,222
-46.6%
0.00%
Q4 2022$1,997,346
+134.2%
225,180
+119.5%
0.00%
Q3 2022$853,000
-23.2%
102,582
-24.4%
0.00%
Q2 2022$1,111,000
-76.7%
135,621
-75.3%
0.00%
Q1 2022$4,775,000
-0.8%
548,241
+8.3%
0.00%
Q4 2021$4,815,000
-44.1%
506,355
-1.0%
0.00%
Q3 2021$8,607,000
+18.1%
511,726
+7.2%
0.00%
Q2 2021$7,288,000
-15.2%
477,258
+8.1%
0.00%
Q1 2021$8,597,000
+8.3%
441,339
+0.2%
0.00%
Q4 2020$7,936,000
-0.5%
440,411
+6.5%
0.00%
-100.0%
Q3 2020$7,976,000
-28.2%
413,470
-2.8%
0.00%0.0%
Q2 2020$11,106,000
+57.2%
425,201
+7.3%
0.00%0.0%
Q1 2020$7,067,000
-48.6%
396,145
-3.8%
0.00%0.0%
Q4 2019$13,738,000
+48.6%
411,694
+6.2%
0.00%0.0%
Q3 2019$9,242,000
-29.6%
387,829
+6.2%
0.00%0.0%
Q2 2019$13,123,000
+362.2%
365,142
+375.0%
0.00%
Q1 2019$2,839,000
+68.1%
76,867
+96.0%
0.00%
Q4 2018$1,689,000
-2.2%
39,225
+7.3%
0.00%
Q3 2018$1,727,000
+11.3%
36,560
+17.3%
0.00%
Q2 2018$1,552,00031,1600.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders